Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYSTEAMINE vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYSTEAMINE vs DABRAFENIB: Safety Overview

Metric CYSTEAMINE DABRAFENIB
Total FAERS Reports 1,663 19,305
Deaths Reported 99 4,165
Death Rate 6.0% 21.6%
Hospitalizations 484 5,325
Average Patient Age 20.3 yrs 58.3 yrs
% Female Patients 53.3% 48.0%
FDA Approval Date Apr 30, 2013 Mar 16, 2023
Manufacturer Horizon Therapeutics USA, Inc. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription